FindTrial
Sign In

Evaluation for the optimal preemptive dose of gabapentin for postoperative pain relief after anorectal surgery

Evaluation for the optimal preemptive dose of gabapentin for postoperative pain relief after anorectal surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022554
Enrollment
Unknown
Registered
2019-04-16
Start date
2019-04-15
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anorectal surgery

Interventions

four groups:gabapentin

Sponsors

General Hospital of Southern Theater Command, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: All patients who were over 18 years of age undergoing surgery and had an ASA Physical Status Classification Score of I, II, or III were offered admission to the study by the study coordinator.

Exclusion criteria

Exclusion criteria: With the exception of patients allergic to the study medications, taking chronic steroids, gabapentin/pregabalin, or narcotics, or experiencing chronic pain or hepatic or renal failure, or were currently pregnant.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Score;nausea and vomitting;—

Countries

China

Contacts

Public ContactXi Wen-Bin

General Hospital of Southern Theater Command, PLA

2974500365@QQ.com+86 13729848200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026